Stay updated with Eskag Pharma’s latest formulations and insights into pharma industry trends through concise and informative blogs and articles.
Anaemia is common once kidneys fail. Blood loss on the circuit, low erythropoietin, and high hepcidin all drain iron. Oral tablets often sit unused in...
Coenzyme Q10 sits at the centre of how cells make energy. It also shields fats inside membranes from oxidative damage. After midlife, the body makes l...
Key Takeaways The Bioavailability Challenge: Standard zinc supplement formats suffer poor gut absorption due to phytate binding and mineral competitio...
Over the past decade, dermatological science has undergone a paradigm shift — moving away from surface-level emollients toward precision-engineered ...
The global nutraceutical industry faces a critical challenge: traditional oral formulations deliver only a fraction of their intended therapeutic valu...
Iron deficiency anaemia remains the most prevalent nutritional disorder globally, yet millions of patients, children, pregnant women, and those with c...
Uneven skin tone, persistent redness, and acne that keeps returning despite a full skincare routine- these are not signs of neglect; they are signs of...
If you struggle to switch off after a long day, you are not alone; stress-driven sleep disruption and cognitive fatigue now affect a significant propo...
India’s sleep aid market is on course to reach USD 699.47 million by 2033, yet standard melatonin tablets deliver well below their stated dose; ...
Key Takeaways The First-Pass Barrier: Traditional oral melatonin tablets suffer from low bioavailability due to rigorous hepatic first-pass metabolism...
Sleep disruption is not simply a lifestyle inconvenience — for millions of shift workers, frequent travellers, and individuals with chronic insomnia...
The sleep supplement industry is undergoing a fundamental transformation. As global consumers increasingly demand evidence-based, high-bioavailability...